Abstract
Objectives
To explore the predictive power of measuring the abdominal fetal fat layer (FFL) as a soft tissue marker at 31, 34, and 37 weeks’ gestation to improve the detection of fetal macrosomia in pregnant women with GDM, in addition to the biometric values with close monitoring of maternal blood sugar level and BMI changes.
Methods
We conducted a prospective observational study at the Department of Obstetrics, University Hospitals, Campus Kiel, Germany, in collaboration with diabetic clinic staff. Participants underwent a third-trimester scan and extra FFL measurements were performed at 31, 34, and 37 weeks of gestation. The clinical outcomes of pregnancy and birth weight were collected from the obstetric record. All of the enrolled women had an early pregnancy ultrasound scan to confirm gestational age.
Results
The FFL at 34 and 37 weeks, with respective cutoff values of >0.48 cm and >0.59 cm, showed a very good sensitivity of 60% for both gestational points, and specificity of 89.3 and 90.6%, respectively. The probability of fetal macrosomia could be more than doubled if the FFL at 34 weeks was more than 0.48 cm. However, the probability of macrosomia dropped to 16% if the FFL was ≤0.48 cm. The median FFLs of macrosomic fetuses at 34 and 37 weeks were 0.50 (IQR 0.10) and 0.60 (IQR 0.25) cm, respectively. The mean age of the study population (n = 80) was 32.26 (SD = 5.06) years. In our study population, ten newborns were born with birth weight >4000 g. The body mass index (BMI) for the mothers of later-onset macrosomic newborns showed higher median values of 30 (IQR 8), 32 (IQR 5), and 33 (IQR 9) at 31, 34, and 37 weeks, respectively, in comparison to mothers of non-macrosomic newborn. However, the BMI did not show any statistically significant difference from those with normal-weight newborn and did not show any specific sensitivity for predicting macrosomia.
Conclusion
Measuring the FFL at 34 and 37 weeks of gestation, in addition to the standard measurement, might be useful for predicting macrosomia and is worth further evaluation.
Similar content being viewed by others
References
Reece EA (2010) The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 23(3):199–203
Zhang X et al (2008) How big is too big? The perinatal consequences of fetal macrosomia. Am J Obstet Gynecol 198(5):517.e1–517.e6
Crosby DA et al (2015) Interpregnancy changes in maternal weight and body mass index. Am J Perinatol 30(2):199–204
Geifman-Holtzman O et al (2010) The clinical utility of oral glucose tolerance test at term: can it predict fetal macrosomia? Arch Gynecol Obstet 281(5):817–821
Hyperglycemia and Adverse Pregnancy Outcome (2009) (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58(2):453–459
Negrato CA et al (2008) Mild gestational hyperglycaemia as a risk factor for metabolic syndrome in pregnancy and adverse perinatal outcomes. Diabetes Metab Res Rev 24(4):324–330
Tian C et al (2016) Excessive weight gain during pregnancy and risk of macrosomia: a meta-analysis. Arch Gynecol Obstet 293(1):29–35
Ventura SJ et al (2000) Births: final data for 1998. Natl Vital Stat Rep 48(3):1–100
Bamberg C, Hinkson L, Henrich W (2013) Prenatal detection and consequences of fetal macrosomia. Fetal Diagn Ther 33(3):143–148
Surkan PJ et al (2004) Reasons for increasing trends in large for gestational age births. Obstet Gynecol 104(4):720–726
Yeh J, Shelton J (2005) Reasons for increasing trends in large for gestational age births. Obstet Gynecol 105(2):444 (author reply 444–445)
Dudley NJ (2005) A systematic review of the ultrasound estimation of fetal weight. Ultrasound Obstet Gynecol 25(1):80–89
Pinette MG et al (1999) Estimation of fetal weight: mean value from multiple formulas. J Ultrasound Med 18(12):813–817
O’Connor C et al (2013) Longitudinal measurement of fetal thigh soft tissue parameters and its role in the prediction of birth weight. Prenat Diagn 33(10):945–951
Esinler D et al (2015) Finding the best formula to predict the fetal weight: comparison of 18 formulas. Gynecol Obstet Invest 80(2):78–84
Bethune M, Bell R (2003) Evaluation of the measurement of the fetal fat layer, interventricular septum and abdominal circumference percentile in the prediction of macrosomia in pregnancies affected by gestational diabetes. Ultrasound Obstet Gynecol 22(6):586–590
Wong SF et al (2001) Sonographic estimation of fetal weight in macrosomic fetuses: diabetic versus non-diabetic pregnancies. Aust N Z J Obstet Gynaecol 41(4):429–432
Faschingbauer F et al (2015) Sonographic weight estimation in fetal macrosomia: influence of the time interval between estimation and delivery. Arch Gynecol Obstet 292(1):59–67
Kehl RJ et al (1996) Fetal growth and body composition in infants of women with diabetes mellitus during pregnancy. J Matern Fetal Med 5(5):273–280
Anblagan D et al (2013) Measurement of fetal fat in utero in normal and diabetic pregnancies using magnetic resonance imaging. Ultrasound Obstet Gynecol 42(3):335–340
West DL, Brans YW (1986) Maternal diabetes and neonatal macrosomia. Dynamic skinfold thickness measurements. Am J Perinatol 3(1):9–12
Lakshmi S et al (2012) Differences in body composition and metabolic status between white UK and Asian Indian children (EarlyBird 24 and the Pune Maternal Nutrition Study). Pediatr Obes 7(5):347–354
Acknowledgements
We thank Professor Walter Jonat for his valuable contribution to the manuscript.
Author information
Authors and Affiliations
Contributions
Mohamed Elessawy: protocol/project development, data collection and management, data analysis, and manuscript writing/editing. Christina Harders: protocol/project development. Helmut Kleinwechter: data collection or management. Norbert Demandt: data collection or management. Ghada Abu Sheasha: data analysis. Nicolai Maass: protocol/project development. Ulrich Pecks: manuscript writing/editing. Christel Eckmann-Scholz: protocol/project development, manuscript editing, and data analysis.
Corresponding author
Ethics declarations
Conflict of interest
All authors indicate they have no financial relationship with the organization and did not receive any sponsorship for the research. We also state that we have had full control of all primary data and agree to allow the journal to review the data if requested. Mohamed Elessawy declares that he has no conflict of interest. Christina Harders declares that she has no conflict of interest. Helmut Kleinwechter declares that he has no conflict of interest. Norbert Demandt declares that he has no conflict of interest. Ghada Abu Sheasha declares that she has no conflict of interest. Nicolai Maass declares that he has no conflict of interest. Ulrich Pecks declares that he has no conflict of interest. Christel Eckmann-Scholz declares that she has no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Elessawy, M., Harders, C., Kleinwechter, H. et al. Measurement and evaluation of fetal fat layer in the prediction of fetal macrosomia in pregnancies complicated by gestational diabetes. Arch Gynecol Obstet 296, 445–453 (2017). https://doi.org/10.1007/s00404-017-4433-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-017-4433-6